The story of Viagra presents a challenging picture for shareholders. While the initial launch generated massive profits, the end of its exclusive rights opened the floodgates to cheaper competitors, dramatically https://thebookmarklist.com/story21599855/the-copyright-and-the-pharmaceutical-industry-a-volatile-bet